Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
78.97
+0.25 (0.32%)
Nov 22, 2024, 4:00 PM EST - Market closed
Hologic Revenue
Hologic had revenue of $987.90M in the quarter ending September 29, 2024, with 4.51% growth. This brings the company's revenue in the last twelve months to $3.99B, down -1.26% year-over-year. In the fiscal year ending September 30, 2023, Hologic had annual revenue of $4.03B, down -17.12%.
Revenue (ttm)
$3.99B
Revenue Growth
-1.26%
P/S Ratio
4.72
Revenue / Employee
$570,472
Employees
6,990
Market Cap
18.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
| Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
| Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
| Sep 26, 2020 | 3.78B | 409.10M | 12.15% |
| Sep 28, 2019 | 3.37B | 149.40M | 4.64% |
| Sep 29, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 24, 2016 | Pro | Pro | Pro |
| Sep 26, 2015 | Pro | Pro | Pro |
| Sep 27, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Molina Healthcare | 37.54B |
| Teva Pharmaceutical | 16.77B |
| Baxter International | 15.06B |
| Labcorp Holdings | 12.71B |
| Quest Diagnostics | 9.54B |
| ICON Public Limited Company | 8.31B |
| Align Technology | 3.96B |
| The Cooper Companies | 3.80B |
HOLX News
- 8 days ago - Hologic to Webcast Presentations at Upcoming Investor Conferences - Business Wire
- 18 days ago - Hologic, Inc. (HOLX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024 - Business Wire
- 5 weeks ago - Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments - Benzinga
- 5 weeks ago - Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women's Health - Business Wire
- 7 weeks ago - Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 - Business Wire
- 7 weeks ago - Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month - Business Wire
- 3 months ago - Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference - Business Wire